| Trial ID: | L0608 |
| Source ID: | NCT00242164
|
| Associated Drug: |
Dialysate Magnesium (Concentration)
|
| Title: |
Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|Arrhythmia
|
| Interventions: |
DRUG: Dialysate Magnesium (Concentration)
|
| Outcome Measures: |
Primary: The primary outcome is the difference in QT dispersion between low dialysate magnesium and normal dialysate magnesium, measurement will be the duration of some changes in the EKG., over one dialysis session |
|
| Sponsor/Collaborators: |
Sponsor: University of Michigan | Collaborators: Renal Research Institute
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
25
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-11
|
| Completion Date: |
2006-11
|
| Results First Posted: |
|
| Last Update Posted: |
2014-12-09
|
| Locations: |
University of Michigan Dialysis Center, Ann Arbor, Michigan, 48104, United States|University of Michigan Dialysis Center, Livonia, Michigan, 48152, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00242164
|
